Marie D’hooghe

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

Secondary progressive in contrast to relapsing‐remitting multiple sclerosis patients show a normal CD4⁺CD25⁺ regulatory T‐cell function and FOXP3 expression

Koen Venken, Niels Hellings, Karen Hensen et al. · Journal of Neuroscience Research · 2006 · 185 citations

Victimization in Chronic Fatigue Syndrome and Fibromyalgia in Tertiary Care: A Controlled Study on Prevalence and Characteristics

Boudewijn Van Houdenhove, Eddy Neerinckx, Roeland Lysens et al. · Psychosomatics · 2001 · 184 citations

Family Medicine, Tertiary Care, Psychological Co-morbidities +8

The <scp>S</scp>ymbol <scp>D</scp>igit <scp>M</scp>odalities <scp>T</scp>est as sentinel test for cognitive impairment in multiple sclerosis

Jeroen Van Schependom, Marie D’hooghe, Krista Cleynhens et al. · European Journal of Neurology · 2014 · 164 citations

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk

Mitja Mitrovič, Nikolaos A. Patsopoulos, Ashley Beecham et al. · Cell · 2018 · 153 citations · Full text